Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008301527> ?p ?o ?g. }
- W2008301527 endingPage "5561" @default.
- W2008301527 startingPage "5554" @default.
- W2008301527 abstract "An effective intranasal (i.n.) vaccine against pneumonic plague was developed. The formulation employed two synthetic lipid A mimetics as adjuvant combined with Yersinia pestis-derived V- and F1-protective antigens. The two nontoxic lipid A mimetics, classed as amino-alkyl glucosaminide 4-phosphates (AGPs) are potent ligands for the Toll-like receptor (TLR) 4. Using a murine (BALB/c) pneumonic plague model, we showed a single i.n. application of the vaccine provided 63% protection within 21 days against a Y. pestis CO92 100 LD50 challenge. Protection reached 100% by 150 days. Using a homologous i.n. 1 degrees /2 degrees dose regimen, with the boost administered at varying times, 63% protection was achieved within 7 days and 100% protection was achieved by 21 days after the first immunization. Little or no protection was observed in animals that received antigens alone, and no protection was observed when the vaccine was administered to BALB/c TLR4 mutant mice. Vaccine-induced serum IgG titers to F1 and V-antigen were reflected in high titers for IgG1 and IgG2a, the latter reflecting a bias for a cell-mediated (TH1) immune response. This intranasal vaccine showed 90% protection in Sprague-Dawley rats challenged with 1000 LD50. We conclude that lipid A mimetics are highly effective adjuvants for an i.n. plague vaccine." @default.
- W2008301527 created "2016-06-24" @default.
- W2008301527 creator A5004199630 @default.
- W2008301527 creator A5025686224 @default.
- W2008301527 creator A5027995217 @default.
- W2008301527 creator A5047114082 @default.
- W2008301527 creator A5056392333 @default.
- W2008301527 creator A5070636674 @default.
- W2008301527 creator A5088949943 @default.
- W2008301527 date "2008-10-01" @default.
- W2008301527 modified "2023-10-18" @default.
- W2008301527 title "Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine" @default.
- W2008301527 cites W1891980138 @default.
- W2008301527 cites W1966410885 @default.
- W2008301527 cites W1971349333 @default.
- W2008301527 cites W1973437236 @default.
- W2008301527 cites W1978793659 @default.
- W2008301527 cites W1981768209 @default.
- W2008301527 cites W1982624589 @default.
- W2008301527 cites W1985158653 @default.
- W2008301527 cites W1986298009 @default.
- W2008301527 cites W1999899245 @default.
- W2008301527 cites W2004162848 @default.
- W2008301527 cites W2013508546 @default.
- W2008301527 cites W2019228627 @default.
- W2008301527 cites W2025675329 @default.
- W2008301527 cites W2041647537 @default.
- W2008301527 cites W2057866626 @default.
- W2008301527 cites W2058799546 @default.
- W2008301527 cites W2064474732 @default.
- W2008301527 cites W2075920575 @default.
- W2008301527 cites W2080004007 @default.
- W2008301527 cites W2088544315 @default.
- W2008301527 cites W2090713460 @default.
- W2008301527 cites W2105005583 @default.
- W2008301527 cites W2108829772 @default.
- W2008301527 cites W2109243910 @default.
- W2008301527 cites W2109427912 @default.
- W2008301527 cites W2114907330 @default.
- W2008301527 cites W2118796896 @default.
- W2008301527 cites W2120412245 @default.
- W2008301527 cites W2121019553 @default.
- W2008301527 cites W2121343519 @default.
- W2008301527 cites W2126953691 @default.
- W2008301527 cites W2128897591 @default.
- W2008301527 cites W2129280927 @default.
- W2008301527 cites W2129319296 @default.
- W2008301527 cites W2135876044 @default.
- W2008301527 cites W2140173657 @default.
- W2008301527 cites W2143895770 @default.
- W2008301527 cites W2145103641 @default.
- W2008301527 cites W2145912774 @default.
- W2008301527 cites W2157289936 @default.
- W2008301527 cites W2158614517 @default.
- W2008301527 cites W2160502767 @default.
- W2008301527 cites W2164094601 @default.
- W2008301527 cites W2166757878 @default.
- W2008301527 cites W2168819347 @default.
- W2008301527 cites W4252590518 @default.
- W2008301527 doi "https://doi.org/10.1016/j.vaccine.2008.08.007" @default.
- W2008301527 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2577737" @default.
- W2008301527 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18722493" @default.
- W2008301527 hasPublicationYear "2008" @default.
- W2008301527 type Work @default.
- W2008301527 sameAs 2008301527 @default.
- W2008301527 citedByCount "18" @default.
- W2008301527 countsByYear W20083015272012 @default.
- W2008301527 countsByYear W20083015272014 @default.
- W2008301527 countsByYear W20083015272016 @default.
- W2008301527 countsByYear W20083015272017 @default.
- W2008301527 countsByYear W20083015272018 @default.
- W2008301527 countsByYear W20083015272020 @default.
- W2008301527 crossrefType "journal-article" @default.
- W2008301527 hasAuthorship W2008301527A5004199630 @default.
- W2008301527 hasAuthorship W2008301527A5025686224 @default.
- W2008301527 hasAuthorship W2008301527A5027995217 @default.
- W2008301527 hasAuthorship W2008301527A5047114082 @default.
- W2008301527 hasAuthorship W2008301527A5056392333 @default.
- W2008301527 hasAuthorship W2008301527A5070636674 @default.
- W2008301527 hasAuthorship W2008301527A5088949943 @default.
- W2008301527 hasBestOaLocation W20083015272 @default.
- W2008301527 hasConcept C104317684 @default.
- W2008301527 hasConcept C142724271 @default.
- W2008301527 hasConcept C147483822 @default.
- W2008301527 hasConcept C159047783 @default.
- W2008301527 hasConcept C203014093 @default.
- W2008301527 hasConcept C22070199 @default.
- W2008301527 hasConcept C2777863537 @default.
- W2008301527 hasConcept C2778059882 @default.
- W2008301527 hasConcept C2778222588 @default.
- W2008301527 hasConcept C2780801004 @default.
- W2008301527 hasConcept C55493867 @default.
- W2008301527 hasConcept C60987743 @default.
- W2008301527 hasConcept C71924100 @default.
- W2008301527 hasConcept C85663871 @default.
- W2008301527 hasConcept C86803240 @default.
- W2008301527 hasConcept C8891405 @default.
- W2008301527 hasConcept C89423630 @default.